(GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter and year ended December 31, 2013. "We... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=22560
/PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the U.S. FDA accepted for standard review the company's New Drug... ...http://in.sys-con.com/node/3012119
/PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease,... ...http://www.asianhhm.com/news/news_archives.asp?NewsID=65034&title=Elusys-Receives-Notice-of-Allowance-from-US-Patent-Office-for-Methods-of-Preventing-or-Treating-Anthrax-with-ETI204-an-AntiAnthrax-Antibody-via-Intramuscular-Injection
Transplant recipients are at extremely high risk of infectious complications because of their immune-compromised state. These patients tolerate... ...http://ehealth.eletsonline.com/2014/03/infectious-complications-after-renal-transplant/
/PRNewswire-USNewswire/ --San Francisco AIDS Foundation has appointed Robert Grant , MD, MPH, as chief medical officer, with special focus on... ...http://www.asianhhm.com/news/news_archives.asp?NewsID=64725&title=Dr-Robert-Grant-Joins-San-Francisco-AIDS-Foundation-as-Chief-Medical-Officer
Impressive Dental Care is a renowned...